The trouble with poor research is it produces poor outcomes.The...

The trouble with poor research is it produces poor outcomes.

The facts are that new tech companies such as BRN was in 2015 had and continue to have a high failure rate. See the following article:

https://www.*.com.au/the-asx-wants-to-block-risky-tech-startups-from-listing-2016-5/amp

Please note that the solution to start up tech failure is to require at least 10 million AUD dollars in capital at time of listing. Brainchip currently has the best part of over 50 million AUD dollars in capital if you take into account the further $US21 million they are entitled to draw on from LDA Capital. So even if they were a startup the risk of failure is negligible based on the ASX research and report.

The fact is that those Tech companies who get through those initial years and make it onto the Technology Index and the ASX 300 As Brainchip has are virtually derisked and highly likely to succeed which is what Brainchip is doing and in fact to claim Brainchip a mature company with customers, world wide patents and product lines pre-sold is ignorant of what the term start up means.

Hopefully this poor attempt at relevance on this thread will fade away.

My opinion only DYOR
FF

AKIDA Ballista